|
91
|
323
|
5hicA |
Egfr kinase domain mutant "tmlr" with a imidazopyridinyl-aminopyrimidine inhibitor |
|
88
|
283
|
5hg7A |
Egfr (l858r, t790m, v948r) in complex with 1-{(3r,4r)-3-[5-chloro-2-(1-methyl-1h-pyrazol-4-ylamino)-7h-pyrrolo[2,3-d]pyrimidin-4-yloxymethyl]-4-methoxy-pyrrolidin-1-yl}propenone (pf-06459988) |
|
200
|
641
|
5he3A |
Bovine grk2 in complex with gbetagamma subunits and ccg224411 |
|
105
|
326
|
5h8gA |
Crystal structure of ck2 with compound 7b |
|
65
|
297
|
5b2kA |
A crucial role of cys218 in the stabilization of an unprecedented auto-inhibition form of map2k7 |
|
78
|
269
|
5hidA |
Braf kinase domain b3ac loop deletion mutant in complex with az628 |
|
102
|
295
|
5iqbA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) in complex with gmppnp, magnesium, and kanamycin a |
|
191
|
639
|
5he2A |
Bovine grk2 in complex with gbetagamma subunits and ccg224406 |
|
97
|
294
|
5hesA |
Human leucine zipper- and sterile alpha motif-containing kinase (zak, mlt, hccs-4, mrk, azk, mltk) in complex with vemurafenib |
|
106
|
298
|
5iqiA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) y237f mutant in complex with gmppnp and magnesium |
|
84
|
269
|
5h9bA |
Drosophila camkii-wt in complex with a fragment of the eag potassium channel and mg2+/amppn |
|
97
|
362
|
5hnbA |
Cdk8-cycc in complex with [6-hydroxy-3-(3-methyl-benzyl)-1h-indazol-5-yl]-((s)-3-hydroxy-pyrrolidin-1-yl)-methanone |
|
114
|
403
|
5hgiA |
Crystal structure of apo human ire1 alpha |
|
91
|
302
|
5hg5A |
Egfr (l858r, t790m, v948r) in complex with n-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide |
|
115
|
331
|
5h8eA |
Crystal structure of ck2 with compound 7h |
|
78
|
280
|
4zegA |
Crystal structure of ttk kinase domain in complex with a pyrazolopyrimidine inhibitor |
|
91
|
324
|
5hczA |
Egfr kinase domain mutant "tmlr" with 3-azetidinyl azaindazole compound 21 |
|
108
|
345
|
4zzmA |
Human erk2 in complex with an irreversible inhibitor |
|
81
|
289
|
5hngA |
Discovery of novel 7-azaindoles as pdk1 inhibitors |
|
92
|
300
|
5hg8A |
Egfr (l858r, t790m, v948r) in complex with n-[3-({2-[(1-methyl-1h-pyrazol-4-yl)amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide |
|
79
|
273
|
5ghvA |
Crystal structure of an inhibitor-bound syk |
|
88
|
266
|
5h2uA |
Crystal structure of ptk6 kinase domain complexed with dasatinib |
|
86
|
307
|
5gjfA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 3 |
|
75
|
295
|
5fp5A |
Structure of cyclin-dependent kinase 2 with small-molecule ligand 4- fluorobenzoic acid (at222) in an alternate binding site. |
|
103
|
296
|
4yp8A |
Irak4-inhibitor co-structure |
|
98
|
313
|
5g6vA |
Crystal structure of the pctaire1 kinase in complex with inhibitor |
|
91
|
308
|
5fxsA |
Igfr-1r complex with a pyrimidine inhibitor. |
|
83
|
307
|
5gjgA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 4 |
|
91
|
306
|
5gjdA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 2 |
|
86
|
296
|
5ax9A |
Crystal structure of the kinase domain of human traf2 and nck-interacting protein kinase in complex with compund 9 |
|
95
|
308
|
5fxqA |
Igfr-1r complex with a pyrimidine inhibitor. |
|
83
|
289
|
5gnkA |
Crystal structure of egfr 696-988 t790m in complex with lxx-6-34 |
|
107
|
356
|
5awmA |
The crystal structure of jnk from drosophila melanogaster reveals an evolutionarily conserved topology with that of mammalian jnk proteins. |
|
71
|
349
|
5ax3A |
Crystal structure of erk2 complexed with allosteric and atp-competitive inhibitors. |
|
112
|
329
|
5b0xA |
Crystal structure of the ck2a/benzoic acid derivative complex |
|
87
|
263
|
5g1xA |
Crystal structure of aurora-a kinase in complex with n-myc |
|
95
|
312
|
5h3qA |
Crystal structure of trka kinase with ligand |
|
127
|
378
|
5ftgA |
Human choline kinase a1 in complex with compound 1-[[4-[2-[4-[[4-(dimethylamino)pyridin-1- yl]methyl]phenoxy]ethoxy]phenyl]methyl]-n,n- dimethyl-pyridin-4-amine (compound 10a) |
|
99
|
309
|
5ftqA |
Crystal structure of the alk kinase domain in complex with cmpd 17 |
|
126
|
378
|
5futA |
Human choline kinase a1 in complex with compound 4-(dimethylamino)-1-{4-[4-(4-{[4-(pyrrolidin- 1-yl)pyridinium-1-yl]methyl}phenyl)butyl]benzyl}pyridinium (compound br25) |
|
89
|
322
|
5feeA |
Egfr kinase domain t790m mutant in complex with a covalent aminobenzimidazole inhibitor. |
|
92
|
264
|
5fbnC |
Btk kinase domain with inhibitor 1 |
|
84
|
268
|
5fboA |
Btk-inhibitor co-structure |
|
75
|
262
|
4ztqA |
Human aurora a catalytic domain bound to fk932 |
|
94
|
295
|
4ztlA |
Irak4-inhibitor co-structure |
|
76
|
294
|
5fp6A |
Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1h-indol-3-yl)prop-2-yn-1-ol (at17833) in an alternate binding site. |
|
90
|
276
|
5av1A |
Crystal structure of dapk1 in the presence of bromide ions. |
|
83
|
306
|
5fdxA |
Structure of ddr1 receptor tyrosine kinase in complex with d2164 inhibitor at 2.65 angstroms resolution. |
|
86
|
268
|
5eykA |
Crystal structure of aurora b in complex with bi 847325 |
|
97
|
309
|
5ftoA |
Crystal structure of the alk kinase domain in complex with entrectinib |
